These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 1653630

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fluorometric assays for DNA topoisomerases and topoisomerase-targeted drugs: quantitation of catalytic activity and DNA cleavage.
    Andrea JE, Adachi K, Morgan AR.
    Mol Pharmacol; 1991 Oct; 40(4):495-501. PubMed ID: 1656189
    [Abstract] [Full Text] [Related]

  • 3. Response of purified mitochondrial DNA topoisomerase I from bovine liver to camptothecin and m-AMSA.
    Lin JH, Castora FJ.
    Arch Biochem Biophys; 1995 Dec 20; 324(2):293-9. PubMed ID: 8554321
    [Abstract] [Full Text] [Related]

  • 4. Increased ATP requirement for activity of and complex formation by DNA topoisomerase II from human leukemic CCRF-CEM cells selected for resistance to teniposide.
    Danks MK, Schmidt CA, Deneka DA, Beck WT.
    Cancer Commun; 1989 Dec 20; 1(2):101-9. PubMed ID: 2561733
    [Abstract] [Full Text] [Related]

  • 5. A defect in DNA topoisomerase II activity in ataxia-telangiectasia cells.
    Mohamed R, Pal Singh S, Kumar S, Lavin MF.
    Biochem Biophys Res Commun; 1987 Nov 30; 149(1):233-8. PubMed ID: 2825700
    [Abstract] [Full Text] [Related]

  • 6. Inactivation of topoisomerase I or II may lead to recombination or to aberrant replication termination on both SV40 and yeast 2 micron DNA.
    Levac P, Moss T.
    Chromosoma; 1996 Oct 30; 105(4):250-60. PubMed ID: 8854885
    [Abstract] [Full Text] [Related]

  • 7. Topoisomerase I and II cleavage of adenovirus DNA in vivo: both topoisomerase activities appear to be required for adenovirus DNA replication.
    Schaack J, Schedl P, Shenk T.
    J Virol; 1990 Jan 30; 64(1):78-85. PubMed ID: 2152835
    [Abstract] [Full Text] [Related]

  • 8. Characterization of a potent catenation activity of HeLa cell nuclei.
    Holden JA, Low RL.
    J Biol Chem; 1985 Nov 25; 260(27):14491-7. PubMed ID: 2997211
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone.
    Drake FH, Hofmann GA, Mong SM, Bartus JO, Hertzberg RP, Johnson RK, Mattern MR, Mirabelli CK.
    Cancer Res; 1989 May 15; 49(10):2578-83. PubMed ID: 2540903
    [Abstract] [Full Text] [Related]

  • 12. Type II DNA topoisomerases: enzymes that can unknot a topologically knotted DNA molecule via a reversible double-strand break.
    Liu LF, Liu CC, Alberts BM.
    Cell; 1980 Mar 15; 19(3):697-707. PubMed ID: 6244895
    [Abstract] [Full Text] [Related]

  • 13. Knotting of the circular duplex DNA by type II DNA topoisomerase from Drosophila melanogaster.
    Hsieh T.
    J Biol Chem; 1983 Jul 10; 258(13):8413-20. PubMed ID: 6305983
    [Abstract] [Full Text] [Related]

  • 14. The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases.
    Lanza A, Tornaletti S, Stefanini M, Evans HH, Ricanati M, Astaldi Ricotti GC, Pedrini AM.
    Carcinogenesis; 1993 Sep 10; 14(9):1759-63. PubMed ID: 8403196
    [Abstract] [Full Text] [Related]

  • 15. Aberrant DNA topoisomerase II activity, radioresistance and inherited susceptibility to cancer.
    Cunningham JM, Francis GE, Holland MJ, Pirollo KF, Chang EH.
    Br J Cancer; 1991 Jan 10; 63(1):29-36. PubMed ID: 1846552
    [Abstract] [Full Text] [Related]

  • 16. Topoisomerase II, not topoisomerase I, is the proficient relaxase of nucleosomal DNA.
    Salceda J, Fernández X, Roca J.
    EMBO J; 2006 Jun 07; 25(11):2575-83. PubMed ID: 16710299
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Analysis of topoisomerase I and II cleavage sites on the Drosophila actin and Hsp70 heat shock genes.
    Kroeger PE, Rowe TC.
    Biochemistry; 1992 Mar 10; 31(9):2492-501. PubMed ID: 1312349
    [Abstract] [Full Text] [Related]

  • 19. Cytogenetic effects of inhibition of topoisomerase I or II activities in the CHO mutant EM9 and its parental line AA8.
    Cortés F, Piñero J, Palitti F.
    Mutat Res; 1993 Aug 10; 288(2):281-9. PubMed ID: 7688089
    [Abstract] [Full Text] [Related]

  • 20. Altered topoisomerase I activity and recombination activating gene expression in a human leukemia cell line resistant to doxorubicin.
    Riou JF, Grondard L, Petitgenet O, Abitbol M, Lavelle F.
    Biochem Pharmacol; 1993 Sep 01; 46(5):851-61. PubMed ID: 8396937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.